SLC5A5 and thyroid gland carcinoma: In vivo studies have shown that the tumor growth-inhibitory effect of [211At]NaAt depends on the amount of NIS expressed in human thyroid carcinomas and is more than six times (per Bq) that of [131I]NaI.